期刊文献+

白细胞介素-11在白血病治疗中的临床应用及研究进展 被引量:7

Progress on Research and Clinical Application of Interleukin-11 in Treatment of Leukemia——Review
下载PDF
导出
摘要 细胞介素 11(IL 11)是一种多功能细胞因子 ,可直接作用于骨髓造血祖细胞、巨噬细胞、T细胞、上皮细胞和肝细胞 ,具有促进造血、调控免疫、抗炎和保护黏膜上皮等功能 ,临床前研究和临床试验已表明IL 11可促进白血病患者化疗后血小板恢复 ,在造血干细胞移植中可防治移植物抗宿主病的发生 ,维持移植物抗白血病效应并可协同G CSF动员造血干 祖细胞进入外周血。本文对IL Interleukin-11 (IL-11) is a multifunctional c yt okine that directly acts on hematopoietic progenitors, macrophage, T cells, epit helial cells and hepatocytes, as well as promotes hematopoiesis, regulates immun ity, protects mucosa and epithelium, and has the effect of anti-inflammatory. P reclinical and clinical studies have demonstrated that IL-11 effectively accele rates the recovery of peripheral blood platelets of acute leukemi a patients after chemothercpy. In the hematopoietic stem cell transplatation, IL -11 prevents and treats the graft- versus-host disease leading to the effect of graft-versus-leukemia. Synergizi ng with G-CSF, IL-11 mobilizes hematopoietic progenitors and stem cells from b one marrow to peripheral blood with higher efficiency. Progress on research and clinical application of IL-11 in treatment of leukemia was reviewed in this pap er.
作者 张秋荣
出处 《中国实验血液学杂志》 CAS CSCD 2004年第5期718-720,共3页 Journal of Experimental Hematology
关键词 细胞因子 白细胞介素-11 白血病 cytokine interleukin-11 leukemia
  • 相关文献

参考文献17

  • 1Hill GR, Ferrara JL. The primacy of the gastrointestional tract as a target organ of acute graft-versus-host disease:rationale for the use zof cytokine shields in allogeneic bone marrow transplantation.Blood, 2000; 95: 2754- 2759 被引量:1
  • 2Trepicchio WL,bozza M, Pedneault G, et al. Recombinant human IL-11 attenuates the inflammatory response through down regulation of proinflammatory cytokine release and nitric oxide production. J Immunol, 1996; 157:3627-3634 被引量:1
  • 3Antin JH, Lee SJ, Neuberg D, et al. A phase 1/11 double-blind,placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogenic stem cell transplantation. Bone marrow transplant, 2002; 29: 373- 377 被引量:1
  • 4Leonard JP, Quinto CM, Kozitza MK, et al. Recombinant human8 interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood, 1994; 83: 1499-1506 被引量:1
  • 5Tafuri A, Lemoli RM, Petrucci MT, et al. Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells. Exp Hematol, 1999; 27: 1255-1263 被引量:1
  • 6Estey EH, Thall PF, Gpiles FJ, et al. Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparis on with idarubicin plus continuous-infus 被引量:1
  • 7TrepicchioWL, Wang L, Bozza M, et al. IL-11 regulates macrophage effector function through the inhibition of nuclear factorKapp B. J mmunol, 1997; 159:5661-5670 被引量:1
  • 8Teshima T, Hill GR, Pan L, et al. IL-11 separate, graft-versusleukemia effects from graft-versus-host disease after bone marrow transplantation. J Clin Invest, 1999; 104: 317 - 325 被引量:1
  • 9Peterson RL,Wang L, Albert L, et al. Moleular effect of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab invest, 1998; 78:1503 - 1512 被引量:1
  • 10Schwertschlag US, Trepicchio WL, Dykstra KH, et al. Hematopoietic immunomodulatory and epithelial effects of interleukin-11.Leukemia, 1999; 13; 1307-1315 被引量:1

二级参考文献9

  • 1Kaushansky K. Use of thrombopoietic growth factors in acute leukemia[J ]. Leukemia, 2000,14(3):505 - 508. 被引量:1
  • 2Teramura M, Kobayashi S, Yoshinaga K, et al. Effect of interleukin 11 on normal and pathological thrombopoiesis[ J ]. Cancer Chemother Pharnacol, 1996, 38(Suppl): S99. 被引量:1
  • 3Green Wood-Van, Meerveld B, Tyler K, et al. Recombinant human interleukin-11 modulates ion transport and mucosal inflammation in the small intestine and colon[J ]. Lab Invest, 2000, 80(8): 1269 - 1280. 被引量:1
  • 4Grosfeld JL, Du X, Williams DA. Interleukin-11: Its biology and prospects for clinical use [ J ]. JPEN J Parenter Enteral Nutr,1999, 23(5 Suppl): S67. 被引量:1
  • 5Gordon MS, McCaskill-Stevens WJ, Battiato LA, et al. A phase I trial recombinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy[J ]. Blood, 1996, 87(9): 3615 - 3624. 被引量:1
  • 6Gordon MS. Thrombopoietic activity of recombinant human interleukin 11 in cancer patients receiving chemotherapy[J ]. Cancer Chemother Pharmacol, 1996, 38(Suppl) :S96. 被引量:1
  • 7Tepler I, Elias L, Smith JW, et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer padents with severe thrombocytopenia due to chemotherapy [ J ].Blood, 1996, 87(9): 3607 - 3614. 被引量:1
  • 8Du X, Williams D. Interleukin 11: Review of molecular, cell biology and clinical use[J]. Blood, 1997, 89(11): 3897 - 3908. 被引量:1
  • 9Kaushansky K. Use of thromboietic growth factors in acute leukemia[J]. Leukemia, 2000, 14(3) :505. 被引量:1

共引文献6

同被引文献30

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部